title: Palbociclib: A breakthrough in breast carcinoma in women.
abstract: Breast cancer (BC) is the most common cancer and leading cause of death in women worldwide. Cellular proliferation, growth, and division are tightly controlled by the cell-cycle regulatory machinery. An important pathway is cyclin-dependent kinases (CDKs) which regulate cell cycle and thus control transcriptional processes. In human cancer, multiple CDK family members are commonly deregulated. The cyclin D-CDK4/6-retinoblastoma (RB) protein-INK4 axis is particularly affected in many solid tumors which leads to cancer cell proliferation. This has led to long-standing interest in targeting CDK4/6 as an anticancer strategy. Different investigational agents that have been tested which inhibit multiple cell cycle and transcriptional CDKs but have carried excessive toxicity thus failed to stand the rational of human use. Amongst several selective and potent inhibitors of CDK4/6, palbociclib is the first to be accessed suitable for human use having explicit selectivity toward CDK4/6. Its mechanism is to arrest cells in G1 phase by blocking RB phosphorylation at CDK4/6-specfic sites without affecting the growth of cells which are RB-deficient. Studies conducted in patients of BC having cells with advanced RB-expression demonstrated acceptable side effects but dose-limiting toxicities primarily neutropenia and thrombocytopenia, with prolonged stable disease in patients.
authors.affiliation: Associate Professor, Dept of Pharmacology, Armed Forces Medical College, Pune 411040, India.
authors.forename: Ajay Kumar
authors.initials: AK
authors.lastname: Gupta
authors.affiliation: Associate Professor, Dept of Pharmacology, Armed Forces Medical College, Pune 411040, India.
authors.forename: Sushil
authors.initials: S
authors.lastname: Sharma
authors.affiliation: Associate Professor, Dept of Pharmacology, Armed Forces Medical College, Pune 411040, India.
authors.forename: Navdeep
authors.initials: N
authors.lastname: Dahiya
authors.affiliation: Associate Professor, Dept of Pharmacology, Armed Forces Medical College, Pune 411040, India.
authors.forename: D B S
authors.initials: DB
authors.lastname: Brashier
keywords: CDK4/6 inhibition; Cyclin-dependent kinases; Retinoblastoma